Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GA2-induced malaria immunity and anti-circumsporozoite antibody interaction study
NL-OMON61454Phase 2Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2026
- Countries
- 1
01
Overview
Phase 2 trial of GA2 in Falciparum malaria (PF), sponsored by Leiden University Medical Center. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
GA2
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on NL-OMON61454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61454.